News Quantified

GOSS – gossamer bio, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

VALERIO THERAPEUTICS: List of the Board Members Positions Held in Other Companies as of March 19, 2025 [Yahoo! Finance]

Gossamer Bio, Inc. (NASDAQ: GOSS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.

Gossamer Bio, Inc. (NASDAQ: GOSS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.

Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

11.5%

BEAT

11.5%

BEAT

11.5%

BEAT

11.5%

BEAT

Form S-8 Gossamer Bio, Inc.

Form 10-K Gossamer Bio, Inc. For: Dec 31

Form 8-K Gossamer Bio, Inc. For: Mar 13

Form 4 Gossamer Bio, Inc. For: Mar 04 Filed by: Peterson Caryn

Form 4 Gossamer Bio, Inc. For: Mar 04 Filed by: Christian Waage

Top News Gainers

4/22 Gossamer Bio Inc (NASDAQ: GOSS) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $30.00 price target on the stock. 12.8%

10/30 Gossamer Bio Inc (NASDAQ: GOSS) is now covered by analysts at Berenberg Bank. They set a "buy" rating on the stock. 8.3%

9/26 Form 4 Gossamer Bio, Inc. For: Sep 26 Filed by: Giraudo Bryan 7.3%

5/14 Gossamer Bio, Inc. (GOSS) CEO Sheila Gujrathi on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] 6.2%

9/9 Form 4 Gossamer Bio, Inc. For: Sep 05 Filed by: Omega Fund V GP Manager, Ltd. 6.0%

3/24 Q4/2019 12/31/2019 EPS -0.890 ZacksConsensus -0.800 ActVsEst (0.090) - Miss 5.8%

4/6 GOSS INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies Gossamer Bio, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm 5.3%

1/13 Form 8-K Gossamer Bio, Inc. For: Jan 13 4.9%

10/31 Gossamer Bio: Risk Prevails Over Future Benefit [Seeking Alpha] 4.9%

12/6 Gossamer Bio Inc (NASDAQ: GOSS) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock. 4.7%

Top News Decliners

9/25 Gossamer Bio Announces Participation in the 2019 Cantor Global Healthcare Conference -9.3%

9/12 Form 4 Gossamer Bio, Inc. For: Sep 10 Filed by: Omega Fund V GP, L.P. -9.3%

12/16 Novartis exit from fevipiprant pressures Gossamer Bio, down 38% premarket [Seeking Alpha] -8.8%

5/30 Form 8-K Gossamer Bio, Inc. For: May 30 -7.2%

11/12 Gossamer Bio, Inc. (GOSS) CEO Sheila Gujrathi on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] -7.1%

3/12 Gossamer Bio Inc (NASDAQ: GOSS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -6.5%

12/17 Gossamer Bio Inc (NASDAQ: GOSS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $25.00 price target on the stock, down previously from $34.00. -6.2%

2/13 Form SC 13G Gossamer Bio, Inc. Filed by: ARCH Venture Fund IX, L.P. -6.0%

2/27 Gossamer Bio Inc (NASDAQ: GOSS) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock. -5.2%

12/18 Gossamer Bio Inc (NASDAQ: GOSS) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -5.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day